Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59

By Barchfeld G.L.   Van Nest G.   Ott G.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1557-1562

Elsevier

Access to resources Recommend Favorite

The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1

By Moore A.   McCarthy L.   Mills K.H.G.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2517-2527

Elsevier

Access to resources Recommend Favorite

Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy

By Iorio A.M.   Francisci D.   Camilloni B.   Stagni G.   De Martino M.   Toneatto D.   Bugarini R.   Neri M.   Podda A.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3629-3637

Elsevier

Access to resources Recommend Favorite

A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2

By Singh M.   Carlson J.R.   Briones M.   Ugozzoli M.   Kazzaz J.   Barackman J.   Ott G.   O'Hagan D.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1822-1827

Elsevier

Access to resources Recommend Favorite

Starch microparticles as vaccine adjuvant

By Rydell Niclas   Stertman Linda   Sjöholm Ingvar  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 5, 2005-09 ,pp. : 807-828

Informa Healthcare

Access to resources Recommend Favorite